NLM Logo

zanubrutinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
zanubrutinib
Unique ID
C000629551
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629551
Entry Term(s)
(7S)-2-(4-phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide
7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide
BGB-3111
Brukinsa
Pharm Action
Antineoplastic Agents
Hematologic Agents
Tyrosine Kinase Inhibitors
Registry Numbers
AG9MHG098Z
0
Heading Mapped to
*Piperidines
*Pyrazoles
*Pyrimidines
Frequency
89
Note
a Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia
Source
Future Oncol. 2018 Sep;14(22):2229-2237.
Date of Entry
2019/01/22
Revision Date
2023/08/04
zanubrutinib Preferred
BGB-3111 Narrower
7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide Broader
Brukinsa Narrower
page delivered in 0.003s